Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

This study has been completed.
Sponsor:
Collaborators:
London School of Hygiene and Tropical Medicine
Medical Research Council Unit, The Gambia
Department of State for Health and Social Welfare, The Gambia
Information provided by:
Gates Malaria Partnership
ClinicalTrials.gov Identifier:
NCT00120809
First received: July 12, 2005
Last updated: July 18, 2005
Last verified: July 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given